Neurogenetics, Part II
Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Neuroscience, Neurology
| Author: | Daniel H. Geschwind, Henry L. Paulson, Christine Klein | ISBN: | 9780444640772 |
| Publisher: | Elsevier Science | Publication: | January 29, 2018 |
| Imprint: | Elsevier | Language: | English |
| Author: | Daniel H. Geschwind, Henry L. Paulson, Christine Klein |
| ISBN: | 9780444640772 |
| Publisher: | Elsevier Science |
| Publication: | January 29, 2018 |
| Imprint: | Elsevier |
| Language: | English |
Neurogenetics, Part II, Volume 148*, the latest release in the Handbook of Clinical Neurology,* provides the latest information on the genetic methodologies that are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is expected to dramatically grow in scope. Part II builds on the foundation of Part I, expanding the coverage to dementias, paroxysmal disorders, neuromuscular disorders, white matter and demyelination diseases, cerebrovascular diseases, adult psychiatric disorders and cancer and phacomatoses.
- Contains comprehensive coverage of neurogenetics
- Details the latest science and its impact on our understanding of neurological, psychiatric disorders
- Presents a focused reference for clinical practitioners and the neuroscience/neurogenetics research community
Neurogenetics, Part II, Volume 148*, the latest release in the Handbook of Clinical Neurology,* provides the latest information on the genetic methodologies that are having a significant impact on the study of neurological and psychiatric disorders. Using genetic science, researchers have identified over 200 genes that cause or contribute to neurological disorders. Still an evolving field of study, defining the relationship between genes and neurological and psychiatric disorders is expected to dramatically grow in scope. Part II builds on the foundation of Part I, expanding the coverage to dementias, paroxysmal disorders, neuromuscular disorders, white matter and demyelination diseases, cerebrovascular diseases, adult psychiatric disorders and cancer and phacomatoses.
- Contains comprehensive coverage of neurogenetics
- Details the latest science and its impact on our understanding of neurological, psychiatric disorders
- Presents a focused reference for clinical practitioners and the neuroscience/neurogenetics research community
